Wealth Enhancement Advisory Services, LLC Iovance Biotherapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 24,735 shares of IOVA stock, worth $57,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,735
Previous 27,451
9.89%
Holding current value
$57,385
Previous $91,000
53.85%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IOVA
# of Institutions
297Shares Held
234MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$67.2 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$58.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$49.2 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$27.4 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $366M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...